Lee Seungwon, Choi Ji Won, Chung In Sun, Kim Duk Kyung, Sim Woo Seog, Kim Tae Jun
Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea.
Therap Adv Gastroenterol. 2023 Aug 24;16:17562848231189957. doi: 10.1177/17562848231189957. eCollection 2023.
The high-flow nasal cannula (HFNC) is a relatively recent method that provides high-flow, heated, humidified gas delivery.
We compared HFNC (group HF) and conventional nasal cannula (NC) (group CO) during deep sedation with propofol and remifentanil for endoscopic submucosal dissection (ESD).
Single-center, retrospective observational cohort study.
In this study, a total of 159 cases were analyzed (group CO, 71 and group HF, 88). We collected the data from electronic medical records from September 2020 to June 2021. The lowest oxygen saturation (SpO), incidence of hypoxia (SpO < 90%), rescue interventions, and adverse events between the two groups were investigated.
There were significant differences between the two groups in lowest SpO and incidence of hypoxia [group CO group HF; 90.3 ± 9.7% 95.7 ± 9.0%, 25 (35.2%) 10 (11.4%); < 0.001, < 0.001; respectively]. Among the rescue interventions, the number of jaw thrust, patient stimulation, O flow increase, and nasal airway insertion were significantly higher in the CO group than in the HF group. However, postprocedural chest X-ray showed higher rates of abnormal findings (atelectasis, aspiration, and pneumoperitoneum) in group HF than in group CO [group CO: 8 (11.3%) group HF: 26 (29.5%), = 0.005]. In multivariable analysis, besides group CO, difficult type of lesion was the risk factor for hypoxia.
Compared to the conventional NC, HFNC provided adequate oxygenation and a stable procedure without significant adverse events during sedation for ESD. However, caution is needed to avoid complications associated with deep sedation and difficult type of lesions.
高流量鼻导管(HFNC)是一种相对较新的方法,可提供高流量、加热、加湿的气体输送。
我们比较了在丙泊酚和瑞芬太尼深度镇静下进行内镜黏膜下剥离术(ESD)时高流量鼻导管(HF组)和传统鼻导管(NC组)(CO组)的情况。
单中心回顾性观察队列研究。
本研究共分析了159例病例(CO组71例,HF组88例)。我们收集了2020年9月至2021年6月电子病历中的数据。调查了两组之间的最低血氧饱和度(SpO)、缺氧发生率(SpO<90%)、抢救干预措施和不良事件。
两组在最低SpO和缺氧发生率方面存在显著差异[CO组 HF组;90.3±9.7% 95.7±9.0%,25例(35.2%) 10例(11.4%);P<0.001,P<0.001]。在抢救干预措施中,CO组的托下颌、刺激患者、增加氧流量和插入鼻气道的次数显著高于HF组。然而,术后胸部X线检查显示HF组的异常发现(肺不张、误吸和气腹)发生率高于CO组[CO组:8例(11.3%) HF组:26例(29.5%),P = 0.005]。在多变量分析中,除了CO组外,病变类型困难是缺氧的危险因素。
与传统鼻导管相比,高流量鼻导管在ESD镇静期间提供了充足的氧合和稳定的操作,且无明显不良事件。然而,需要谨慎避免与深度镇静和病变类型困难相关的并发症。